SRPT:NASDAQ
Sarepta Therapeutics Inc
17,50 USD
arrow_upward
+1,10%(+0,19) 1D
17,69 USD
arrow_upward
+1,09% (+0,19)bedtimeNakon radnog vremena
Zatvoreno: 7. lis, 16:00:00 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za SRPT...
Otvori
17,28 USD
Najviša
17,66 USD
Najniža
16,98 USD
Trž. kap.
1,85 mlr.
Prosj. kol.
3,01 mil.
Količina
75,00
52-tjed. najviša
25,32 USD
52-tjed. najniža
14,69 USD
EPS
−1,66 USD
Beta
0,38
Dionice u optjecaju
105,63 mil.
Broj djelatnika
835
Otvori
17,28 USD
Najviša
17,66 USD
Najniža
16,98 USD
Trž. kap.
1,85 mlr.
Prosj. kol.
3,01 mil.
Količina
75,00
52-tjed. najviša
25,32 USD
52-tjed. najniža
14,69 USD
EPS
−1,66 USD
Beta
0,38
Dionice u optjecaju
105,63 mil.
Broj djelatnika
835
Vijesti
Iz web-izvora i od partnera za vijesti
Simply Wall Street
·
prije 4 sata
Sarepta Therapeutics (SRPT) ELEVIDYS Data Puts Its Valuation Story Back In Focus
Insider Monkey
·
prije 12 sati
Jim Cramer Explains His Hesitation Over Sarepta (SRPT) Therapeutics
AD HOC NEWS
·
prije 1 dan
Sarepta Therapeutics stock faces a USD 5.00 Sell target
AD HOC NEWS
·
prije 1 dan
HC Wainwright reiterates Sell for Sarepta Therapeutics stock
Profil
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Sarepta Therapeutics Inc – informacije
Glavni izvršni direktorDouglas S. Ingram
Zaposlenici835
Osnovano1980
Sjedište-
Sektor-
Web-lokacijasarepta.com